ENLIVEN THERAPEUTICS financial statements

인라이븐 테라퓨틱스NASDAQ:ELVN · Nasdaq · Healthcare · sector #17
$42.39-6.77%
2026-10-06 close

ENLIVEN THERAPEUTICS's published financial data is dated 2026-10-04. 2024 revenue was $0M. 2024 operating profit was −$105M.

Reported results

ENLIVEN THERAPEUTICS notifications

Quantus Signal · live data · not investment advice · Privacy Policy
Q